Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Rimoquin Injection

Prescription Icon
Prescription Required

Marketer

Anglo-French Drugs & Industries Ltd

Salt Composition

Chloroquine (64.5mg)

Overview Rimoquin Injection

Malarex injection combats malaria parasites, preventing and treating the disease. Its mechanism involves eliminating the causative parasite, thus halting infection spread. Administration is strictly via injection by a qualified healthcare provider; self-injection is prohibited. Mosquito bite prevention is crucial; employ insect repellent on exposed skin, spray indoor areas, and wear light-colored, protective clothing after dusk. Potential side effects include weakness, nausea, vomiting, rash, and itching; gastrointestinal upset (diarrhea, abdominal pain, appetite loss) may also occur. Injection site reactions (pain, swelling, redness) are possible. Persistent side effects warrant medical attention. Diabetic patients should inform their physician, as Malarex may induce hypoglycemia, necessitating regular blood sugar monitoring. Blurred vision may occur, prompting routine eye exams. Prolonged use may require regular blood cell count monitoring. Report any unexplained bleeding or bruising, sore throat, fever, or fatigue to your doctor immediately.

Primary Ingredients of Rimoquin Injection

No text provided to rephrase.

Uses of Rimoquin Injection

Managing Malaria Infections

Major Benefits of Rimoquin Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Rimoquin Injection:

  • Weakness
  • Rash
  • Headache
  • Dizziness
  • Vomiting
  • Nausea
  • Stomach pain
  • Loss of appetite
  • Diarrhea

How to use Rimoquin Injection:

Administering this medication requires a healthcare professional; please do not attempt self-medication.

How Rimoquin Injection works:

Rimoquin Injection combats malaria, an infection caused by parasites. Its mechanism involves elevating blood haem levels, a substance harmful to the malaria parasite. This elevated toxicity eliminates the parasite, thus halting disease progression.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Rimoquin Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Rimoquin Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Rimoquin Injection poses no known breastfeeding safety concerns. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent risk to the infant.

DrivingDrivingUNSAFE

Administering Rimoquin Injection may induce adverse reactions impacting driving capabilities. Occasional side effects include blurred vision or impaired visual focus, potentially hindering safe driving.

KidneyKidneyCAUTION

Rimoquin Injection requires careful administration in individuals with impaired kidney function. A modified Rimoquin Injection dosage may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Rimoquin Injection cautiously; dosage modification may be necessary. Physician consultation is recommended. Routine liver function tests may be advisable during treatment.

What if you forget to take Rimoquin Injection :

NA

Facts to Know About Rimoquin Injection

LabelValue
Pharmaceutical Category A derivative of 4-aminoquinoline
Potential for Dependence None.
Medication Classification Eye medication.
Mechanism of Action Aminoquinoline antimalarials

FAQs on Rimoquin Injection

Rimoquin Injection serves as an antimalarial medication, employed in both the treatment and prevention of malaria.
Malaria symptoms can emerge within a week of an infected mosquito bite. More commonly, however, these symptoms manifest between seven and eighteen days post-infection. Early malaria symptoms resemble influenza, characterized by chills and fever, myalgia, nausea, cephalgia, and diarrhea.
Prolonged use of Rimoquin Injection, as prescribed by your physician, necessitates regular eye examinations. This is due to the chloroquine content, which can induce blurred vision, reading difficulties (manifesting as disappearing text), and, infrequently, retinopathy with extended treatment.
Consult your physician regarding any history of psoriasis prior to commencing treatment with Rimoquin Injection, as it could potentially exacerbate the condition.
This medication may cause abdominal discomfort, nausea, vomiting, or headache in some patients. These adverse effects are frequently mitigated by ingesting the medication with food.
Insufficient clinical evidence supports the efficacy of chloroquine in COVID-19 treatment. Consequently, using Rimoquin Injection for COVID-19 without physician consultation is ill-advised.
Allow at least four hours to elapse between taking an antacid and other medications.
Both hydroxychloroquine and chloroquine initially received regulatory approval for malaria treatment. Hydroxychloroquine, however, exhibits a superior safety profile compared to chloroquine, which has a significantly higher incidence of adverse reactions. Consequently, hydroxychloroquine enjoys greater prevalence in current medical practice. Furthermore, unlike chloroquine, hydroxychloroquine holds approval for the management of rheumatoid arthritis and lupus.
Mosquito-borne malaria can be avoided through preventative measures such as wearing protective clothing, employing mosquito nets, and using insect repellents. Consult your physician regarding the necessity of antimalarial medication. If prescribed, ensure accurate dosage and complete the full course of treatment as directed.
Rimoquin Injection serves as an antimalarial medication, employed in both the treatment and prevention of malaria.
Malaria symptoms can emerge within a week of an infected mosquito bite. The incubation period typically ranges from seven to eighteen days post-infection. Early malaria symptoms mimic influenza, encompassing chills, fever, myalgia, nausea, cephalalgia, and diarrhea.
Prolonged use of Rimoquin Injection, as directed by your physician, necessitates routine eye examinations. This is due to the potential for chloroquine, a component of this medication, to induce blurred vision, reading difficulties (manifesting as apparent word disappearance), and, infrequently, retinopathy.
Consult your physician regarding any history of psoriasis prior to commencing treatment with Rimoquin Injection, as it could potentially exacerbate the condition.
Abdominal discomfort, nausea, vomiting, and headache are frequently reported adverse reactions associated with this medication. Consuming the medication with food may often lessen the severity of these effects.
Insufficient clinical evidence supports the use of chloroquine in COVID-19 treatment. Consequently, Rimoquin Injection should not be used for COVID-19 without prior physician consultation.
Allow at least four hours to elapse between taking an antacid and other medications.
Both hydroxychloroquine and chloroquine initially gained approval as malaria treatments. Hydroxychloroquine, however, enjoys greater current usage due to a lower incidence of adverse reactions compared to chloroquine. Furthermore, hydroxychloroquine's therapeutic applications extend to rheumatoid arthritis and lupus, unlike chloroquine.
Protect yourself from malaria by employing preventative measures such as wearing long sleeves and trousers to avoid mosquito bites, sleeping under a mosquito net, and applying insect repellent. Consult your physician regarding the necessity of antimalarial medication. If prescribed, ensure you adhere to the correct dosage and complete the entire course of the prescribed antimalarial drug.
Rimoquin Injection
13
MRP 16
17% off